Efficacy and safety of intratonsillar immunotherapy for allergic rhinitis: A randomized, double-blind, placebo-controlled clinical trial

This publication has 39 references indexed in Scilit:

• Induction and maintenance of allergen-specific FOXP3+ Treg cells in human tonsils as potential first-line organs of oral tolerance
  Journal of Allergy and Clinical Immunology, 2012
• IgG antibodies produced during subcutaneous allergen immunotherapy mediate inhibition of basophil activation via a mechanism involving both FcγRIIA and FcγRIIB
  Immunology Letters, 2010
• Intralymphatic allergen administration renders specific immunotherapy faster and safer: A randomized controlled trial
  Proceedings of the National Academy of Sciences, 2008
• Allergic Rhinitis and its Impact on Asthma (ARIA) 2008*
  Allergy, 2008
• Allergy immunotherapy among Medicaid-enrolled children with allergic rhinitis: Patterns of care, resource use, and costs
  Journal of Allergy and Clinical Immunology, 2008
• Health‐related quality of life in allergic rhinitis: comparing the short form ESPRINT‐15 and MiniRQLQ questionnaires
  Allergy, 2007
• Recommendations for standardization of clinical trials with Allergen Specific Immunotherapy for respiratory allergy. A statement of a World Allergy Organization (WAO) taskforce
  Allergy, 2007
• The effectiveness of measures to change the indoor environment in the treatment of allergic rhinitis and asthma: ARIA update (in collaboration with GA²LEN)
  Allergy, 2005
• Climate and the prevalence of symptoms of asthma, allergic rhinitis, and atopic eczema in children
  Occupational and Environmental Medicine, 2004
• Prevention of new sensitizations in asthmatic children monosensitized to house dust mite by specific immunotherapy. A six‐year follow‐up study.
  Clinical & Experimental Allergy, 2001